Methotrexate for rheumatoid arthritis: what should the patient be told?
作者信息
Ostor A J K, O'Gradaigh D R, Jenner J R
出版信息
Rheumatology (Oxford). 2003 Dec;42(12):1576-8. doi: 10.1093/rheumatology/keg419.
PMID:14645872
Abstract
摘要
相似文献
1
Methotrexate for rheumatoid arthritis: what should the patient be told?
Rheumatology (Oxford). 2003 Dec;42(12):1576-8. doi: 10.1093/rheumatology/keg419.
2
[Two fatal cases of methotrexate-induced interstitial pneumonitis].[两例甲氨蝶呤诱发的间质性肺炎致死病例]
Nihon Kokyuki Gakkai Zasshi. 2002 Mar;40(3):249-55.
3
Interstitial pneumonitis associated with infliximab therapy.英夫利昔单抗治疗相关的间质性肺炎
J Rheumatol. 2006 Jun;33(6):1189-93. Epub 2006 Apr 15.
4
Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis.甲氨蝶呤与类风湿关节炎间质性肺病的进展无关。
Arch Intern Med. 2008 Sep 22;168(17):1927-8. doi: 10.1001/archinte.168.17.1927.
5
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Nihon Rinsho. 2005 Jan;63 Suppl 1:566-72.
6
Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.间质性肺炎与抗肿瘤坏死因子-α治疗
J Rheumatol. 2007 Jan;34(1):238-9; author reply 239.
7
Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.间质性肺疾病的急性进展：依那西普的一种并发症，尤其在存在类风湿性肺病和甲氨蝶呤治疗的情况下。
Rheumatology (Oxford). 2006 Aug;45(8):1048-9. doi: 10.1093/rheumatology/kel090. Epub 2006 Jun 7.
8
[Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].[甲氨蝶呤治疗类风湿关节炎患者的严重不良反应]
Duodecim. 1998;114(21):2187-90.
9
Hodgkin's disease following methotrexate therapy for rheumatoid arthritis.类风湿关节炎患者接受甲氨蝶呤治疗后发生霍奇金淋巴瘤。
N Z Med J. 2002 Jun 21;115(1156):293-4.
10
[Methotrexate pneumonitis].[甲氨蝶呤肺炎]
Praxis (Bern 1994). 1999 Mar 25;88(13):573-8.
Zotero 插件